IVIG vs plasma exchange: which works best for myasthenic crisis?
NCT ID NCT07532707
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments—intravenous immunoglobulin (IVIG) and plasma exchange (PLEX)—for people experiencing a myasthenic crisis, a severe episode of muscle weakness in myasthenia gravis. Fifty adults were treated with either IVIG or PLEX, and their improvement was measured after 14 days. The goal is to see which treatment is more effective and identify common triggers for these crises.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Intravenous Immunoglobulin (IVIG) and Plasma Exchange (PLEX)
What this could lead to
If this study shows one treatment works better, it could help doctors choose the best option for managing severe myasthenic crises.
What could go wrong
This is a small, single-center study with only 50 participants, so results may not apply broadly. It compares two existing treatments, not a new breakthrough.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS (MG) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Damascus University
Damascus, Syria